搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 6 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 6 日前... efforts to combat surging opioid-related deaths by teaming with a maker of generic< ... ...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 5 日前, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 5 日前Annmarie Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 5 日前Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 6 日前Pfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired ...
Bayer must face US company's flea and tick drug antitrust lawsuit
Reuters· 4 日前, opens new tab must face a U.S. antitrust lawsuit accusing a former unit of the German company ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 4 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
6 Job Boards And Companies Hiring Remote Freelance Writers In 2024
Forbes· 7 日前With more than 60% of writers in the U.S. being freelance writers, and with freelance writing ...
United Airlines Turns To Generative AI To Help Explain Flight Delays
Forbes· 3 日前Every flight delay happens for a reason, but passengers don’t always get the full story. United ...